Repurposing losartan for fibrostenosing Crohn’s disease: a compelling preclinical rationale - Quiz - MDSpire

Repurposing losartan for fibrostenosing Crohn’s disease: a compelling preclinical rationale

  • By

  • Luca Massimino

  • Virginia Solitano

  • Federica Ungaro

  • September 23, 2025

  • 0 min

Share

Original Source(s)

Repurposing losartan for fibrostenosing Crohn’s disease: a compelling preclinical rationale

  • by Luca Massimino, Virginia Solitano, Federica Ungaro

  • September 23, 2025

Related Content

Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment

Bioinformatics-driven insights: rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury

Assessment of the quality and dependability of Crohn's disease-related information on Douyin and Xiaohongshu: Insights from user feedback in a cross-sectional analysis